• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
INFI

INFI

Infinity Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.01

-0.01 (-52.38%)

Company Profile

CEO

Seth A. Tasker

IPO Date

2000-07-28

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.02

Prev. Close

$0.02

Day Low

$0.01

Day High

$0.01

52W Low

$0.01

52W High

$1.30

Market Cap

$0.00B

Volume

2.48M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

26.7%

Avg Negative

11.2%

Avg Neutral

61.9%

News Feed

INFI Stock: Why Infinity Pharmaceuticals Is Soaring After Tuesday's Plunge

InvestorPlace·7/28/2021·↑ positive

INFI Stock Increases Over 71% Intraday: Why It Happened

Pulse2·7/28/2021·↑ positive

Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC)

Business Wire
·7/27/2021
·↑ positive

Infinity Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Company Update

Business Wire·7/27/2021·↑ positive

Infinity Pharmaceuticals Hosting Webinar on MARIO-3 and MARIO-275 Phase 2 Trials

Business Wire·7/20/2021·↑ positive

Infinity to Present at The Keystone Symposia Precision Oncology Meeting

Business Wire·6/14/2021·↑ positive

Infinity Pharmaceuticals' (INFI) CEO Adelene Perkins on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/13/2021·↓ negative

Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/13/2021·↓ negative

Infinity Pharmaceuticals: Q1 Earnings Insights

Benzinga·5/13/2021·↓ negative

Infinity Announces the Date of Its First Quarter 2021 Financial Results Conference Call and Webcast

Business Wire·5/6/2021·↑ positive